Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202505742818730Not yet recruiting
Randomised trial of tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by Emmanuel Dare Adaramoye. Primary endpoint: Intraoperative blood loss. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202505742818730.